ACASTI PHARMA INC. Share · CA00430K8656 · ACST · A3EP78 (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ACASTI PHARMA INC.
No Price
Company Profile for ACASTI PHARMA INC. Share
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Company Data
Name ACASTI PHARMA INC.
Company Acasti Pharma Inc.
Symbol ACST
Website
https://www.acastipharma.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3EP78
ISIN CA00430K8656
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Prashant Kohli
Market Capitalization 34 Mio
Country Canada
Currency EUR
Employees 0,0 T
Address 3009 boulevard de la Concorde East, H7E 2B5 Laval
IPO Date 2012-02-07
Stock Splits
| Date | Split |
|---|---|
| 10.07.2023 | 1:6 |
| 31.08.2021 | 1:8 |
| 15.10.2015 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | A1P0.F |
| NASDAQ | ACST |
More Shares
Investors who hold ACASTI PHARMA INC. also have the following shares in their portfolio:
